Cargando…
Sitagliptin is effective and safe as add-on to insulin in patients with absolute insulin deficiency: a case series
INTRODUCTION: It is generally believed that incretin-based therapies are effective in patients possessing certain levels of preserved β-cell function. So far, there are no reports that show the effectiveness of dipeptidyl peptidase-4 inhibitors in patients who absolutely lack the capacity for endoge...
| Autor principal: | |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2011
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3079672/ https://www.ncbi.nlm.nih.gov/pubmed/21443773 http://dx.doi.org/10.1186/1752-1947-5-117 |